- Home
- SYNX vs GOVX Comparison
SYNX vs GOVX Comparison
Compare SYNX & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- GOVX
- Stock Information
- Founded
- SYNX 2005
- GOVX 2001
- Country
- SYNX Israel
- GOVX United States
- Employees
- SYNX N/A
- GOVX N/A
- Industry
- SYNX
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- GOVX Health Care
- Exchange
- SYNX Nasdaq
- GOVX Nasdaq
- Market Cap
- SYNX 15.6M
- GOVX 17.1M
- IPO Year
- SYNX 2024
- GOVX N/A
- Fundamental
- Price
- SYNX $2.61
- GOVX $2.43
- Analyst Decision
- SYNX
- GOVX Strong Buy
- Analyst Count
- SYNX 0
- GOVX 5
- Target Price
- SYNX N/A
- GOVX $14.20
- AVG Volume (30 Days)
- SYNX 7.9K
- GOVX 3.6M
- Earning Date
- SYNX 11-26-2024
- GOVX 11-12-2024
- Dividend Yield
- SYNX N/A
- GOVX N/A
- EPS Growth
- SYNX N/A
- GOVX N/A
- EPS
- SYNX N/A
- GOVX N/A
- Revenue
- SYNX $9,893,000.00
- GOVX $3,090,161.00
- Revenue This Year
- SYNX $52.34
- GOVX N/A
- Revenue Next Year
- SYNX N/A
- GOVX $565.58
- P/E Ratio
- SYNX N/A
- GOVX N/A
- Revenue Growth
- SYNX 18.05
- GOVX N/A
- 52 Week Low
- SYNX $2.10
- GOVX $1.09
- 52 Week High
- SYNX $4.10
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- SYNX 36.82
- GOVX 51.87
- Support Level
- SYNX $2.50
- GOVX $2.31
- Resistance Level
- SYNX $2.94
- GOVX $3.88
- Average True Range (ATR)
- SYNX 0.25
- GOVX 0.32
- MACD
- SYNX -0.01
- GOVX 0.10
- Stochastic Oscillator
- SYNX 33.90
- GOVX 31.92
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.